Market Value191,082,000
Total Holdings44
File Date2016-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
GNMX / Aevi Genomic Medicine, Inc.
NBRV / Nabriva Therapeutics Plc
FOMX / Foamix Pharmaceuticals Ltd.
FGEN / FibroGen, Inc.
CYNA / Cynapsus Therapeutics Inc.
NBSE / NeuBase Therapeutics, Inc.
LOXO / Loxo Oncology, Inc.
US16706W1027 / Chiasma Inc
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
45780VAA0 / Inotek Pharmaceuticals Corporation Bond
NDRM / NeuroDerm Ltd.
ABEO / Abeona Therapeutics Inc.
GBT / Global Blood Therapeutics Inc.
AXGN / Axogen, Inc.
ZGNX / Zogenix Inc
/ Immunomedics, Inc.
YMTX / Yumanity Therapeutics Inc
PRTA / Prothena Corporation plc
/ Achaogen Inc
HZNP / Horizon Therapeutics Plc
US00163U1060 / AMAG Pharmaceuticals, Inc.
INNL / Innocoll Holdings plc
NKTR / Nektar Therapeutics
H03579101 / Auris Medical Holding Ltd
EVOK / Evoke Pharma, Inc.
ACRS / Aclaris Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
ALPN / Alpine Immune Sciences, Inc.
CMRX / Chimerix, Inc.
ADMS / Adamas Pharmaceuticals Inc
MDVN / Medivation, Inc.
SUPN / Supernus Pharmaceuticals, Inc.
CORI / Corium International, Inc.
IL0011177958 / Intec Pharma Ltd
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ASRT / Assertio Holdings, Inc.
XENE / Xenon Pharmaceuticals Inc.
ISEE / IVERIC bio Inc
ARIA / ARIAD Pharmaceuticals, Inc.
0PP / Portola Pharmaceuticals Inc
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation
PDSB / PDS Biotechnology Corporation
TENX / Tenax Therapeutics, Inc.
XOMA / XOMA Royalty Corporation
TVTX / Travere Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
CARA / Cara Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
MGNX / MacroGenics, Inc.
SAGE / Sage Therapeutics, Inc.
EGRX / Eagle Pharmaceuticals, Inc.
CTMX / CytomX Therapeutics, Inc.
AFMD / Affimed N.V.
TGTX / TG Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
CDXS / Codexis, Inc.
HROW / Harrow, Inc.